Today: 9 June 2026

Roman Perkowski

American Airlines Shares Edge Up, Fuel Costs Remain Key

American Airlines Shares Edge Up, Fuel Costs Remain Key

American Airlines shares rebounded 1.5% to $13.50 Friday on heavy volume after a weeklong slide, as the carrier trimmed some summer flying amid soaring jet fuel costs that could add $4–$5 billion to annual expenses; investors now face uncertainty over whether fare hikes and premium demand can offset margin pressure, with AAL’s market value at $8.9 billion and the sector bracing for further volatility.
6 June 2026
·
Exxon Mobil Stock Slipped Friday. Why XOM’s Next Move May Come From Oil, Not Earnings

Exxon Mobil Stock Slipped Friday. Why XOM’s Next Move May Come From Oil, Not Earnings

Exxon Mobil shares rose 3.2% for the week to $149.92, outperforming the S&P 500’s 2.64% drop, as investors weigh low global oil inventories and potential price spikes—with senior VP Neil Chapman warning Brent could hit $150-160 if supplies tighten further—against signs of demand destruction and upcoming inflation data that could sway Fed policy.
6 June 2026
···
Enphase Drops 18% Ahead of Market Open

Enphase Drops 18% Ahead of Market Open

Enphase Energy plunged 18% to $56.07 Friday, underperforming solar peers as U.S. jobs data sent bond yields higher and revived interest rate fears; the stock ended the week 12% below Monday’s close, with Q1 revenue down 18% and U.S. demand off 48% from last quarter, putting Monday’s open in sharp focus for investors.
6 June 2026
·
AI-driven stocks stall on Wall Street after jobs report shakes chip sector

AI-driven stocks stall on Wall Street after jobs report shakes chip sector

Chip stocks plunged Friday, with Broadcom down 4.5% and Nvidia 3.7%, after a stronger-than-expected May jobs report fueled fears the Fed may delay or reverse rate cuts, slamming AI-linked shares that powered this year’s rally; Broadcom’s revenue and AI chip forecast missed Wall Street estimates, triggering a 4.7% drop in the semiconductor ETF as investors demanded perfection.
5 June 2026
····
Quantinuum slips premarket after $1.68 billion IPO debut

Quantinuum slips premarket after $1.68 billion IPO debut

Quantinuum shares dropped 2.52% to $58.86 in premarket trading, slipping below their $60 IPO price after raising $1.68 billion in an upsized offering, as investors weigh early-stage financials—$5.2 million Q1 revenue against a $136.6 million net loss—and uncertainty over the company’s ability to turn quantum computing promise into repeatable commercial contracts.
5 June 2026
·
Lululemon Slashes Outlook, Raising Pressure on Incoming CEO

Lululemon Slashes Outlook, Raising Pressure on Incoming CEO

Lululemon slashed its annual revenue and profit forecasts due to weak U.S. demand, sending shares down about 9% in after-hours trading; the company now expects fiscal 2026 revenue of $11.00–$11.15 billion and EPS of $10.95–$11.15, both below previous guidance, as gross margin fell and U.S. sales dropped despite international growth.
4 June 2026
·
Planet Labs tops revenue estimates, faces next challenges

Planet Labs tops revenue estimates, faces next challenges

Planet Labs smashed revenue estimates with a record $94.2 million, up 42% year-over-year, as government and defense demand drove backlog up 72% to $906 million, but net loss ballooned to $138.9 million due to a $106.5 million warrant-liability revaluation tied to the share price surge; Planet forecast Q2 revenue of $102–$107 million and adjusted EBITDA profit of up to $5 million.
4 June 2026
·
Micron Drops as AI Memory Stocks Take a Hit

Micron Drops as AI Memory Stocks Take a Hit

Micron Technology plunged 8.3% to $989.46 after a chip-sector selloff triggered by Broadcom’s revenue miss, but analysts say the memory-chip shortage could last years, with Morgan Stanley raising its target to $1,050; risks remain as Raymond James warns DRAM and NAND prices may peak mid-2026, and supply chain groups caution AI data centers are straining chip availability.
4 June 2026
······
1 2 3 4 … 6

Stock Market Today

  • J.M. Smucker Shares Rise After Earnings Beat Despite Sales Warning
    June 9, 2026, 10:05 AM EDT. J.M. Smucker shares rose 3.16% in pre-market trading after the company reported a 20% rise in adjusted earnings per share to $2.77, beating Wall Street estimates. The packaged-food firm grew net sales by 6% to $2.27 billion in Q4 but issued a cautionary note, forecasting a 3-4% decline in annual sales for fiscal 2027, below analysts' expectations of 1% growth. CEO Mark Smucker highlighted a focus on organic volume growth and profit improvement amid shifts in industry pricing strategies. Coffee sales drove quarterly results with a 12% retail sales increase but volume declines. The company flagged risks including consumer shifts to store brands, weight-loss drug impacts, and tariff fluctuations. Smucker's outlook balances lower sales with improved profitability.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Go toTop